Coherus BioSciences, Inc. is a late-stage clinical biologics platform company, which engages in the development and commercializition of biosimilar therapeutics worldwide. It focuses on global biosimilar market. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar, and Steve Glover in September 2010 and is headquartered in Redwood City, CA.
Market Cap | 579.565 Million | Shares Outstanding | 77.275 Million | Avg 30-day Volume | 1.179 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -2.77 |
Price to Revenue | 3.6876 | Debt to Equity | 4.1778 | EBITDA | -255.052 Million |
Price to Book Value | 12.322 | Operating Margin | -80.8015 | Enterprise Value | 1.195 Billion |
Current Ratio | 3.643 | EPS Growth | -3.352 | Quick Ratio | 3.268 |
1 Yr BETA | 1.2743 | 52-week High/Low | 19.32 / 5.6 | Profit Margin | -88.0055 |
Operating Cash Flow Growth | -124.2836 | Altman Z-Score | -0.9505 | Free Cash Flow to Firm | -131.968 Million |
Earnings Report | 2022-08-04 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
0 | 2022-05-18 | 2 | |
|
0 | 2022-05-04 | 3 | |
VEXLER VLADIMIR CHIEF SCIENTIFIC OFFICER |
|
103,963 | 2022-04-01 | 3 |
STILWELL MCDAVID CHIEF FINANCIAL OFFICER |
|
69,680 | 2022-04-01 | 3 |
|
40,000 | 2022-02-25 | 3 | |
|
0 | 2022-02-02 | 2 | |
|
27,000 | 2022-01-07 | 3 | |
|
27,000 | 2022-01-07 | 2 | |
|
27,000 | 2022-01-07 | 2 | |
LANFEAR DENNIS M PRESIDENT & CEO |
|
1,505,657 | 2022-01-04 | 2 |
ANICETTI VINCENT R CHIEF OPERATING OFFICER |
|
274,790 | 2021-07-06 | 1 |
|
20,000 | 2021-05-21 | 0 | |
VIRET JEAN-FREDERIC CHIEF FINANCIAL OFFICER |
|
61,295 | 2021-02-01 | 0 |
|
0 | 2021-01-11 | 0 | |
|
0 | 2021-01-11 | 0 | |
|
0 | 2021-01-11 | 0 | |
|
0 | 2020-01-10 | 0 | |
|
0 | 2020-01-10 | 0 | |
V-SCIENCES INVESTMENTS PTE LTD |
|
7,381,116 | 2019-12-30 | 0 |
HORTON DARLENE P SEE REMARKS |
|
0 | 2019-01-18 | 0 |
FINCK BARBARA K CHIEF MEDICAL OFFICER |
|
37,043 | 2018-09-10 | 0 |
|
1,940,914 | 2018-02-01 | 0 | |
WATLER PETER K. CHIEF TECHNICAL OFFICER |
|
5,900 | 2018-02-01 | 0 |
HERMAN ALAN C. CHIEF SCIENTIFIC OFFICER |
|
350,624 | 2017-12-15 | 0 |
|
No longer subject to file | 2016-08-08 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
No longer subject to file | 2014-11-12 | 0 | |
|
5,893,736 | 2012-03-27 | 0 | |
|
59,785 | 2010-10-15 | 0 | |
ROMANO ANTHONY EVP - CHIEF OPERATING OFFICER |
|
40,637 | 2010-10-15 | 0 |
FOGARTY JAMES P PRESIDENT AND CEO |
|
125,000 | 2010-06-24 | 0 |
LEVITT JAY PRESIDENT - FASHION BUG |
|
42,331 | 2010-06-08 | 0 |
|
18,000 | 2010-04-07 | 0 | |
|
98,195 | 2009-07-01 | 0 | |
|
132,263 | 2009-04-14 | 0 | |
WOOLF BRIAN PRESIDENT - LANE BRYANT |
|
20,000 | 2009-01-23 | 0 |
|
122,222 | 2008-12-19 | 0 | |
|
53,187 | 2008-07-11 | 0 | |
DESABATO ANTHONY A EVP - CORP. & LABOR RELATIONS |
|
115,022 | 2007-03-26 | 0 |
SPECTER ERIC M EVP - CHIEF FINANCIAL OFFICER |
|
186,577 | 2007-03-26 | 0 |
STERN COLIN D EVP, GENERAL COUNSEL & SEC. |
|
127,500 | 2007-03-26 | 0 |
SULLIVAN JOHN J VP - CONTROLLER |
|
68,647 | 2007-03-26 | 0 |
BARON JOSEPH M EVP/CHIEF OPERATING OFFICER |
|
189,341 | 2007-03-26 | 0 |
VARMA GALE H EVP - HUMAN RESOURCES |
|
103,689 | 2007-03-26 | 0 |
BOURLON MICHEL EVP-SOURCING |
|
71,906 | 2007-03-26 | 0 |
BLOISE JAMES G EVP SUPPLY CHAIN, TECH. & BSC |
|
87,653 | 2007-03-26 | 0 |
BERN DORRIT J PRESIDENT & CEO |
|
1,172,612 | 2007-02-08 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-05-20 16:58:22 -0400 | 2022-05-18 | A | 54,000 | a | 54,000 | direct | ||||||||||
2022-05-06 18:50:55 -0400 | 2022-05-04 | A | 54,000 | a | 54,000 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 22:15:03 UTC | 1.1556 | 0.4144 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 21:45:03 UTC | 1.1556 | 0.4144 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 21:15:03 UTC | 1.1556 | 0.4144 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 20:45:04 UTC | 1.1556 | 0.4144 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 20:15:04 UTC | 1.1556 | 0.4144 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 19:45:03 UTC | 1.1556 | 0.4144 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 19:15:03 UTC | 1.1556 | 0.4144 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 18:45:03 UTC | 1.1555 | 0.4145 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 18:15:04 UTC | 1.1555 | 0.4145 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 17:45:03 UTC | 1.1555 | 0.4145 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 17:15:03 UTC | 1.1555 | 0.4145 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 16:45:03 UTC | 1.1527 | 0.4173 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 16:15:03 UTC | 1.1527 | 0.4173 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 15:45:04 UTC | 1.1527 | 0.4173 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 15:15:03 UTC | 1.1527 | 0.4173 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 14:45:04 UTC | 1.1527 | 0.4173 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 14:15:03 UTC | 1.1527 | 0.4173 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 13:45:04 UTC | 1.1494 | 0.4206 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 13:15:04 UTC | 1.1494 | 0.4206 | 350000 |
COHERUS BIOSCIENCES INC CHRS | 2022-06-27 12:45:03 UTC | 1.1494 | 0.4206 | 350000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Morningstar Funds Trust- Morningstar Alternatives Fund | CHRS | -23296.0 shares, $-287938.56 | 2022-01-31 | N-PORT |
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund | CHRS | -41720.0 shares, $-491878.8 | 2022-02-28 | N-PORT |
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund | CHRS | -3576.0 shares, $-46166.16 | 2022-03-31 | N-PORT |
Guidestone Funds- Strategic Alternatives Fund | CHRS | -16384.0 shares, $-211517.44 | 2022-03-31 | N-PORT |
JNL Series Trust- JNL Multi-Manager Alternative Fund | CHRS | -59511.0 shares, $-768287.01 | 2022-03-31 | N-PORT |
LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio | CHRS | -44412.0 shares, $-573358.92 | 2022-03-31 | N-PORT |
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund | CHRS | -35520.0 shares, $-458563.2 | 2022-03-31 | N-PORT |
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND | CHRS | -33111.0 shares, $-427463.01 | 2022-03-31 | N-PORT |
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund | CHRS | -117790.0 shares, $-1064821.6 | 2022-04-30 | N-PORT |